Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation [letter]

Nemunaitis, J; Anasetti, C; Buckner, CD; Appelbaum, FR; Shannon-Dorcy, K; Hansen, J; Singer, JW

doi:10.1182/blood.V81.3.865.865

J Nemunaitis,

J Nemunaitis

Search for other works by this author on:

This Site

PubMed

Google Scholar

C Anasetti,

C Anasetti

Search for other works by this author on:

This Site

PubMed

Google Scholar

CD Buckner,

CD Buckner

Search for other works by this author on:

This Site

PubMed

Google Scholar

FR Appelbaum,

FR Appelbaum

Search for other works by this author on:

This Site

PubMed

Google Scholar

K Shannon-Dorcy,

K Shannon-Dorcy

Search for other works by this author on:

This Site

PubMed

Google Scholar

J Hansen,

J Hansen

Search for other works by this author on:

This Site

PubMed

Google Scholar

JW Singer

Search for other works by this author on:

This Site

PubMed

Google Scholar

Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation [letter]

Article PDF first page preview

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology

Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation [letter]

Article PDF first page preview

Contents

Data & Figures

Supplemental data

References

Related

Related

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only